ReMinded

24/09/2025

Presenting season has started🎙️

Last week, we proudly brought home the grand prize 🏆 at the Deal Making Summit Pitch Competition in NYC, securing $10,000 in non-dilutive funding to fuel our mission of improving outcomes in mental healthcare with cortisol monitoring💡

Now, we’re equally thrilled to share that ReMinded has been selected as a Top 25 Quarterfinalist in the .usa 2025 Pitch Competition looking to secure the main prize of $30,000! 🚀

Both moments represent belief in the work we’re doing to make psychiatry smarter and more intentional, powered by physiological stress data.

👉 Learn more about the eosera® competition at eosera.com/pages/pitch

17/08/2025

A few weeks ago, our Co-Founder & CEO, Annika Lundström, took the stage at the United Nations to speak on women- and youth-led innovation and leadership in NYC.

At ReMinded, we believe in showing what it really looks like to step into unfamiliar industries, with courage, resilience, and authenticity. Progress doesn’t come without challenge, and that pushing boundaries is simply the cost of entry to creating real change.

💡 In a world where women remain underrepresented in leadership, we’re proud to be building a female-founded, globally diverse MedTech company, proving every day that results matter more than stereotypes.

Thank you to the Permanent Mission of Finland to the UN, Nuorten Agenda 2030, and Jenni Palukka for making this initiative possible, and for bringing together voices that inspire the next generation of innovators. 🙌

Here’s to more leaps of faith, more women leading, and a healthier future for all. 🫡

17/08/2025

17/06/2025

ReMinded has received approval to initiate our Investigational Device Exemption (IDE) study for our saliva-based cortisol detection test! 🎉

This marks a major milestone in our clinical validation journey toward FDA clearance (anticipated in Q4 2025) and brings us one step closer to transforming how mental health conditions are measured and managed.

Our team is deeply committed to advancing accessible, non-invasive solutions, and this IDE approval validates both the strength of our science and the urgency of our mission.

Stay tuned as we enter this clinical phase and continue driving innovation in mental health care. More updates coming soon.

05/03/2025

ReMinded was honored to join the Global Health Innovators Spotlight panel at the Frontiers Summit 2025 by Phase Capital last week in Nashville, Tennessee. 💫

Change is driven by bold actions, and Annika, Adil, and Sanjida are actively pushing the boundaries of what’s possible with saliva-based cortisol sensors this year.🔬

A huge thank you to the Wond’ry at Vanderbilt University and the Nashville community for warmly welcoming our CEO once again.

09/02/2025

Reflecting on nearly a year of progress, ReMinded is grateful for the abundant opportunities we’ve had in the U.S. so far. The support and innovation we’ve experienced, particularly in Nashville, have played a pivotal role in our success. We’re thrilled to head to the Frontiers Summit 2025, where our CEO, Annika Lundström, will be part of the Global Biotech Innovation panel, contributing to discussions that are shaping the future of healthcare.

📅 When: February 27-28, 2025
📍 Where: Noah Liff Opera Center, Nashville, TN
Summit Website + Tickets: https://phasecapital.co/frontiers-summit/



28/01/2025

Check out our latest feature on 🎉 Dive into how we’re making mental health care more measurable with rapid cortisol testing and transforming the way stress is assessed. 🚀Article linked in the comments👇🏼

07/01/2025

Huge congratulations to our talented co-founder Adil Shah for being awarded a spot on the Dean’s List at Aalto University for the 2023-2024 academic year! 🏆

This accomplishment is especially meaningful as Adil continues to lead as CTO at ReMinded, where he’s been driving innovation in design, hardware, and software development. 🚀

Adil’s contributions are making a big impact and we’re so proud of all his achievements this past year! 👏

Here’s to more growth and success in 2025! 🌟

15/09/2024

ReMinded is expanding its reach on the East Coast and will be presenting at the MedInvest Conferences for Biotech & Pharma in NYC on September 18-19, 2024! 🎤

Joined by 125+ top investors, life sciences leaders, and 40+ Presenting Companies, we look forward to connecting with key players and sharing insights on the future of behavioural health while discussing the latest advancements and innovations in the healthcare industry.🩺

23/08/2024

We are proud to publicly announce the closing of our Pre-Seed round, raising approximately $500,000.🎉

A warm welcome goes to Kodori Ventures as a key investor in this round. Kodori Ventures is focused on redefining the future of mental health by supporting companies that are pioneering transformative, data-centred innovations. Their focus on driving scientific research and creating tailored treatment solutions aligns seamlessly with our mission. Together, we aim to shift the way society views and prioritizes mental health, setting a new standard in the industry.

A special thanks also goes out to Arben Ventures, the dedicated angels who have supported us from the beginning, and the innovation grant from ELY-keskus - Centre for Economic Development, Transport and the Environment. Your collective belief in our vision is what makes this journey possible.

23/07/2024

We’ve been slightly quiet on here, but that doesn’t mean things have been on hold—quite the contrary! 🚀✨ Here’s a summary of the past months’ activities for our team:

1️⃣ Website Redesign: Our website just got a fresh new look! 💻✨ Check out our redesigned site where our device gets showcased for the first time, designed by our CTO, Adil Shah.

2️⃣ TEDxCSTU Speaker: In the middle of a longer-term move to San Francisco, our CEO, Annika, got selected to give a TED Talk at the TEDxCSTU Event on July 28th in Milpitas, CA! 🎤 From sharing our journey to inspiring others, this is a dream come true.

3️⃣Grant Award: We’re excited to have received a grant from Vanderbilt University and NSF! 🌟 A huge shoutout to our COO, Emilia Vartiainen, for her dedication and hard work during the innovation program which took place now in June.

Thanks for your continued support and stay tuned for more updates! 💪🏽